Bradykinin Receptor Antagonists
DBCAT001656Pharmacologic class
Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS. A DrugBank category of 4 drugs. 1 of them is approved.
- Also known as
- Antagonists, Bradykinin · Antagonists, Bradykinin Receptor · Bradykinin Antagonists · Bradykinin Receptor Blockers · Bradykinin Receptor Inhibitors
What you can answer from here — as of May 31, 2018
Which targets do Bradykinin Receptor Antagonists share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account